MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Gene

• Publication date

  2016-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.gene.2015.11.045PMID 26656176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-340 reverses cisplatin resistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.

  2015cited by this paper
• EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.

  2015cited by this paper
• Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro

  2015cited by this paper
• miR-340 suppresses glioblastoma multiforme

  2015cited by this paper
• PI3K/AKT pathway-mediated regulation of p27Kip1 is associated with cell cycle arrest and apoptosis in cervical cancer

  2015cited by this paper
• Expression of p27 and PTEN and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence.

  2015cited by this paper
• Functional characterization of OPN in human laryngeal squamous cell carcinoma and its xenograft model in nude mice.

  2015cited by this paper
• miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2.

  2015cited by this paper
• Osteopontin Promotes EZH2 Expression and Tumor Progression in Nasopharyngeal Carcinoma

  2014cited by this paper
• Immunohistochemical expression of p27(kip1) in metastatic laryngeal squamous cell carcinoma.

  2014cited by this paper
• EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27Kip1 Downregulation

  2014cited by this paper
• miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer

  2014cited by this paper
• Role of EZH2 in oral squamous cell carcinoma carcinogenesis.

  2014cited by this paper
• Decreased miR-340 Expression in Bone Marrow Is Associated with Liver Metastasis of Colorectal Cancer

  2014cited by this paper
• Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis

  2013cited by this paper
• The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer

  2013cited by this paper
• MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.

  2013cited by this paper
• miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect.

  2012cited by this paper
• MicroRNA and cancer

  2012cited by this paper
• EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

  2012cited by this paper
• A complex Polycomb issue: the two faces of EZH2 in cancer.

  2012cited by this paper
• The molecular pathogenesis of head and neck squamous cell carcinoma.

  2012cited by this paper
• MicroRNA expression profiles in human colorectal cancers with liver metastases.

  2011cited by this paper
• miR‐340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c‐Met

  2011cited by this paper
• Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage

  2011cited by this paper
• The tumor suppressor gene rap1GAP is silenced by mir-101-mediated EZH2 overexpression in invasive squamous cell carcinoma

  2011cited by this paper
• EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo

  2011cited by this paper
• Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

  2010cited by this paper
• Regulation of tumor angiogenesis by EZH2.

  2010cited by this paper
• Roles of the EZH2 histone methyltransferase in cancer epigenetics.

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract.

  1989cited by this paper
• Dysplasia, in situ carcinoma, and progression to invasive squamous cell carcinoma of the upper aerodigestive tract.

  1989cited by this paper

• Caspase 3/8/9 Apoptotic Pathway Deregulation Analysis in Laryngeal Squamous Cell Carcinoma.

  2025cites this paper
• A synthetic circular RNA targeting miR-340-5p promotes optic nerve regeneration and retinal ganglion cell survival following axotomy.

  2025cites this paper
• EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas

  2025cites this paper
• Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review

  2023cites this paper
• The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.

  2023cites this paper
• microRNA-150 targets major epigenetic repressors and inhibits cell proliferation.

  2022cites this paper
• Mechanism of miR-340-5p in laryngeal cancer cell proliferation and invasion through the lncRNA NEAT1/MMP11 axis.

  2022cites this paper
• miR-340: A multifunctional role in human malignant diseases

  2021influential citation
• miR-340-5p is reduced in laryngeal carcinoma and hinders tumor survival by targeting ROCK1

  2021cites this paper
• A novel circular RNA circPPFIA1 promotes laryngeal squamous cell carcinoma progression through sponging miR-340-3p and regulating ELK1 expression

  2021cites this paper
• Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated EZH2 stabilization

  2021cites this paper
• The expression of microRNA-340 and cyclin D1 and its relationship with the clinicopathological characteristics and prognosis of lung cancer.

  2021cites this paper
• Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact

  2020cites this paper
• The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.

  2020cites this paper
• Carcinogenic roles and therapeutic effects of EZH2 in gynecological cancers.

  2020cites this paper
• High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.

  2019cites this paper
• Long noncoding RNA SOX2‐OT facilitates laryngeal squamous cell carcinoma development by epigenetically inhibiting PTEN via methyltransferase EZH2

  2019cites this paper
• Effect of EZH2 knockdown on preimplantation development of porcine parthenogenetic embryos.

  2019cites this paper
• MiR-340-5p alleviates oxygen-glucose deprivation/reoxygenation-induced neuronal injury via PI3K/Akt activation by targeting PDCD4.

  2019cites this paper
• Effects of miR-340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines

  2019cites this paper
• MiR-340/iASPP axis affects UVB-mediated retinal pigment epithelium (RPE) cell damage.

  2018cites this paper
• MicroRNA-340 inhibits the growth and invasion of angiosarcoma cells by targeting SIRT7.

  2018cites this paper
• microRNA-340 influences cell proliferation, apoptosis and invasion by targeting NF-κB1 in gastric cancer.

  2018cites this paper
• Low expression of microRNA‐340 confers adverse clinical outcome in patients with acute myeloid leukemia

  2018cites this paper
• MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.

  2018cites this paper
• MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2

  2017cites this paper
• Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians

  2017cites this paper
• MicroRNA‑340 inhibits tumor cell proliferation, migration and invasion, and induces apoptosis in hepatocellular carcinoma.

  2017cites this paper
• MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma

  2017cites this paper
• microRNA-340 induces apoptosis by downregulation of BAG3 in ovarian cancer SKOV3 cells.

  2017cites this paper
• Targeting MicroRNAs in Cancer Gene Therapy

  2017cites this paper
• MiR‐101‐3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2

  2017cites this paper
• EZH2 deletion promotes spermatogonial differentiation and apoptosis.

  2017cites this paper
• MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling

  2017cites this paper
• EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?

  2017cites this paper
• DNA Methylation and Dysregulation of miRNA in Cancer

  2017cites this paper
• MicroRNAs associated with the pathogenesis of multiple sclerosis.

  2016cites this paper
• A Novel Inflammation- and Nutrition-Based Prognostic System for Patients with Laryngeal Squamous Cell Carcinoma: Combination of Red Blood Cell Distribution Width and Body Mass Index (COR-BMI)

  2016cites this paper